# Nutritional Interventions in Osteoarthritis: Mechanisms, Clinical Evidence, and Translational Opportunities

**Authors:** Milan Patel, Gabriela Betanzos, Marco Troka, Jay Modi, George Nageeb, Alan D. Kaye, Alaa Abd-Elsayed

PMC · DOI: 10.3390/nu18020244 · 2026-01-13

## TL;DR

This paper reviews how diet and specific nutrients can help manage osteoarthritis by reducing pain and inflammation, offering a more holistic treatment approach.

## Contribution

The paper synthesizes preclinical, clinical, and translational evidence on nutritional interventions for osteoarthritis, emphasizing plant-derived compounds and delivery systems.

## Key findings

- Whole-diet approaches like Mediterranean and plant-based diets improve OA symptoms and biomarkers.
- Bioactive compounds such as curcumin and omega-3s show anti-inflammatory and chondroprotective effects.
- Nanoparticle delivery systems improve nutraceutical effectiveness and targeting in OA treatment.

## Abstract

Osteoarthritis (OA) is a leading cause of chronic pain worldwide. This is driven by progressive cartilage degradation, inflammation, oxidative stress, and metabolic dysfunction. Current pharmacologic interventions mostly lead to symptomatic relief without actually affecting disease progression. Thus, there is a growing interest in the development of new interventional methods. Our review seeks to synthesize preclinical, translational, and clinical evidence on the impact nutritional methods have on OA management. Whole-diet approaches, such as Mediterranean and plant-based, have been linked to reduced pain, increased physical function, and positive biomarker changes. Bioactive compounds, including curcumin, polyphenols, omega-3 fatty acids, and select herbal extracts, have shown anti-inflammatory, antioxidant, and chondroprotective effects via NF-κB, Nrf2, AMPK, and SIRT1 pathways. This review particularly focuses on plant-derived substances. Emerging nanoparticle technology with regard to advanced delivery systems shows initial promise in nutraceutical pharmacokinetics and tissue targeting. Overall, nutritional interventions are adjunct interventions to OA management. Although these are not full treatment replacements, dietary modifications and targeted nutraceutical strategies with improved delivery systems may lead to more preventive, personalized, and holistic OA management and care.

## Linked entities

- **Proteins:** NFKB1 (nuclear factor kappa B subunit 1), GABPA (GA binding protein transcription factor subunit alpha), PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1), SIRT1 (sirtuin 1)
- **Chemicals:** curcumin (PubChem CID 969516), omega-3 fatty acids (PubChem CID 56842239)
- **Diseases:** osteoarthritis (MONDO:0005178)

## Full-text entities

- **Genes:** SIRT1 (sirtuin 1) [NCBI Gene 23411] {aka SIR2, SIR2L1, SIR2alpha}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1) [NCBI Gene 5562] {aka AMPK, AMPK alpha 1, AMPKa1}, NFE2L2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 4780] {aka IMDDHH, NRF2, Nrf-2}
- **Diseases:** metabolic dysfunction (MESH:D008659), inflammation (MESH:D007249), pain (MESH:D010146), OA (MESH:D010003), cartilage degradation (MESH:D002357), chronic pain (MESH:D059350)
- **Chemicals:** curcumin (MESH:D003474), omega-3 fatty acids (MESH:D015525), polyphenols (MESH:D059808)

---
Source: https://tomesphere.com/paper/PMC12844890